reglab/housing_qa huggingface dataset:
MD. Health - General Code Ann. §  18-324 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part IV - Tuberculosis|Section 18-324 - Control of Communicable Tuberculosis

    (a)    The Secretary or a health officer may have an individual examined, if the Secretary or the health officer knows or is notified in writing by a physician that the individual is suspected of having tuberculosis.    (b)    (1)    If, after the examination, the Secretary or the health officer finds that the individual has tuberculosis and that the condition of the individual endangers, or may endanger, the public health of the community, the Secretary or the health officer may order the individual to receive appropriate medical care.        (2)    If the individual fails to comply with the order, the Secretary or the health officer may order the individual to be placed in any of the following types of medical quarantine in order to protect the public health:            (i)    Medical isolation at home;            (ii)    Domiciliary care, nursing home care, or hospital care; or            (iii)    Other medically appropriate living arrangement.        (3)    The order of the Secretary or the health officer may also contain such other conditions as the Secretary or the health officer believes are necessary to protect either the health of the infected individual or the public health.    (c)    The Secretary or a health officer may not require an individual to have a physical examination, other than a chest X–ray and to render sputum samples. The Secretary or a health officer may not restrict the right of the individual to select a treatment method, if the individual:        (1)    In good faith relies on spiritual means through prayer for healing; and        (2)    Complies with the laws, rules, and regulations that relate to sanitation for and quarantine of infectious, contagious, and communicable diseases.
MD. Health - General Code Ann. §  18-325 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part IV - Tuberculosis|Section 18-325 - Prohibited Acts; Penalty

    (a)    An individual may not refuse to comply with the placement ordered under § 18-324 of this subtitle.    (b)    While an individual is in any placement for tuberculosis treatment, the individual may not:        (1)    Behave in a disorderly manner; or        (2)    Leave the placement before being discharged properly.    (c)    An individual who violates any provision of this section is guilty of a misdemeanor and on conviction shall be imprisoned in a penal institution with facilities for tuberculosis treatment until the Secretary or the Health Department of Baltimore City finds that the condition of the individual no longer endangers the health of the community, or the Secretary obtains a court order that states that the individual:        (1)    Is to be moved to a specified less restrictive setting for continuation of treatment;        (2)    Must comply with the treatment until the Secretary determines the treatment has been completed;        (3)    May not behave in a disorderly manner or leave the placement until the Secretary determines that the individual has completed the treatment; and        (4)    Following a hearing, will be reimprisoned until the Secretary determines that the individual has completed the treatment, if the individual does not comply with the terms of the order.
MD. Health - General Code Ann. §  18-328 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part V - Pertussis|Section 18-328 - Definitions

    (a)    In Part V of this subtitle, the following words have the meanings indicated.    (b)    “Health care provider” means any licensed health care professional, organization, or institution, whether public or private, under whose authority pertussis vaccine is administered.    (c)    “Major adverse reaction” means:        (1)    Any serious illness, disability, or impairment of mental, emotional, behavioral, or physical functioning or development, the first manifestation of which appears within 7 days after the date of administration of pertussis vaccine and for which there is reasonable scientific or medical evidence that pertussis vaccine causes, or significantly contributes to, such effect; and        (2)    Any other reaction, which the Department, after consultation with the Medical and Chirurgical Faculty of Maryland, determines by guideline is a basis for not continuing with pertussis vaccine administration.    (d)    “Pertussis vaccine” means any vaccine that contains materials intended to prevent the occurrence of pertussis, whether or not the materials are administered separately or in conjunction with other materials intended to prevent the occurrence of other diseases.
MD. Health - General Code Ann. §  18-329 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part V - Pertussis|Section 18-329 - Required Information

    (a)    (1)    Prior to the administration of pertussis vaccine, the health care provider shall provide to the individual’s parent or guardian written information, satisfying the requirements of this subsection, and by appropriate inquiries attempt to elicit the information necessary to make the determinations required by § 18-332(b) of this subtitle.        (2)    The information required under paragraph (1) of this subsection shall include:            (i)    The frequency, severity, and potential long-term effects of pertussis;            (ii)    Possible adverse reactions to pertussis vaccine which, if they occur, should be brought to the immediate attention of the health care provider;            (iii)    A form listing symptoms to be monitored and containing places where information can be recorded to assist in reporting to the health care provider, local health officer, and the Department;            (iv)    Measures parents should take to reduce the risk of, or to respond to, any major adverse reaction;            (v)    Early warning signs or symptoms to which parents should be alert as possible precursors to a major adverse reaction;            (vi)    When and to whom parents should report any major adverse reaction;            (vii)    A summary of the immunization requirements adopted under § 7-403(a) of the Education Article, including those related to pertussis vaccine; and            (viii)    The information required under § 18-332(a)(1) through (3) of this subtitle.    (b)    The Department by guideline and consistent with § 18-331(b) of this subtitle shall prescribe the form and content of the information provided to parents in accordance with this section.
MD. Health - General Code Ann. §  18-330 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part V - Pertussis|Section 18-330 - Records

    (a)    At the time of administration of pertussis vaccine to an individual, the health care provider shall record in a permanent record to which the patient or the patient’s parent or guardian shall have access on request:        (1)    The date of each vaccination;        (2)    The manufacturer and lot number of the vaccine used for each;        (3)    Any other identifying information on the vaccine used; and        (4)    The name and title of the health care provider.    (b)    Within 24 hours any health care provider who has administered pertussis vaccine to an individual and has reason to believe that the individual has had a major adverse reaction to the vaccine shall:        (1)    Record all relevant information in the individual’s permanent medical record; and        (2)    Report the information, including the manufacturer’s name and lot number, to the local health officer who shall immediately forward the information to the Department. On receipt of the information, the Department shall immediately notify the vaccine manufacturer.
MD. Health - General Code Ann. §  18-331 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part V - Pertussis|Section 18-331 - Collection of Data

    (a)    By guideline, the Department shall establish a system, sufficient for the purposes of subsections (b) and (c) of this section, to collect data from the local health officers, from public and private health care providers, and from parents on the incidence of pertussis and major adverse reactions to pertussis vaccine.    (b)    On the basis of information collected under this subsection and of other information available, the Department shall periodically revise and update the information required by § 18–329 of this subtitle and the guidelines adopted under § 18–332 of this subtitle.    (c)    The Department shall report to the United States Centers for Disease Control and Prevention all information collected under subsection (a) of this section, including that received under § 18–330(b) of this subtitle.
MD. Health - General Code Ann. §  18-332 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part V - Pertussis|Section 18-332 - Adoption of Guidelines

    (a)    The Department shall adopt guidelines, after notice and public hearing in accordance with the Administrative Procedure Act, setting forth:        (1)    The circumstances under which pertussis vaccine should not be administered;        (2)    The circumstances under which administration of the vaccine should be delayed;        (3)    Any categories of potential recipients who are significantly more vulnerable to major adverse reactions than is the general population; and        (4)    Procedures to notify all physicians of the content of the final guidelines and all updates issued thereafter.    (b)    The administration of pertussis vaccine to an individual may not be required by any provision of law if, in the physician’s medical judgment:        (1)    The circumstances specified under subsection (a)(1) or (2) of this section are present; or        (2)    Taking into account the information specified under subsection (a)(3) of this section as well as all other relevant information, the risk to the potential recipient outweighs the benefits both to the potential recipient and to the public in administering the vaccine.    (c)    Nothing in this section shall be construed to affect any emergency authority of the Secretary under any other provision of law to protect the public health.
MD. Health - General Code Ann. §  18-333 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part VI - Acquired Immune Deficiency Syndrome (Aids)|Section 18-333 - Acquired Immune Deficiency Syndrome (Aids) Research and Information Program

    (a)    (1)    The Secretary shall establish and promote a statewide public information program on acquired immune deficiency syndrome (AIDS).        (2)    The public information program shall:            (i)    Attempt to reach individuals at risk for contracting AIDS;            (ii)    Encourage those individuals at risk for contracting AIDS to take the necessary precautions to prevent transmission of the HTLV-III virus; and            (iii)    Include any other aspects that the Secretary considers appropriate.    (b)    The Secretary shall establish a program to train physicians, physician’s assistants, nurses, and other health professionals in:        (1)    Diagnosing and treating AIDS or other conditions associated with AIDS; and        (2)    Methods to prevent the transmission of the HTLV-III virus.    (c)    To carry out this section, the Secretary:        (1)    On request, shall receive the help of or information from any agency of this State or of a political subdivision; and        (2)    May contract for any necessary services.    (d)    The Secretary may set a sliding fee schedule for services provided under this section.
MD. Health - General Code Ann. §  18-334 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part VI - Acquired Immune Deficiency Syndrome (Aids)|Section 18-334 - Donors of Semen, Blood, or Tissue

    (a)    (1)    In this section the following words have the meanings indicated.        (2)    “HIV” means the human immunodeficiency virus that causes acquired immune deficiency syndrome.        (3)    “Institution” means:            (i)    An ambulatory surgical facility or center, as defined in § 19-114 of this article;            (ii)    A health maintenance organization, as defined in § 19-701 of this article;            (iii)    A hospital or related institution, as defined in § 19-301 of this article;            (iv)    A tissue bank; or            (v)    The office of 1 or more physicians.        (4)    “Laboratory” means a public laboratory, medical laboratory, or medical test unit as those terms are defined in Title 17 of this article.        (5)    “Physician” means a person licensed to practice under Title 14 of the Health Occupations Article.        (6)    (i)    “Tissue bank” means an establishment that obtains, stores, processes, distributes, or sells human blood or other human tissue for use in the human body.            (ii)    “Tissue bank” includes a blood bank or sperm bank.    (b)    (1)    Subject to the provisions of paragraph (2) of this subsection, an institution that obtains or processes semen, blood, or tissue shall obtain and send a blood sample from each potential donor of semen, blood, or tissue to a laboratory approved by the Department to test for HIV antibodies.        (2)    Before obtaining a blood sample from a potential semen, blood, or tissue donor the institution shall:            (i)    Inform the potential donor, in layman’s terms, that a blood sample of the donor will be tested for HIV antibodies and if the donor’s blood sample tests positive for HIV antibodies the result will be reported to the Department; and            (ii)    Obtain written consent from the potential donor on a form provided by the Department for the administration of the HIV antibody tests and for the disclosure of a positive test result to the Department.    (c)    An institution that obtains a positive HIV antibody test result under subsection (b) of this section shall:        (1)    Notify the potential donor from whom the blood sample was obtained of the positive result;        (2)    Inform the individual of available counseling; and        (3)    Report the result to the Department on the form the Department provides.    (d)    A test result reported by an institution under subsection (c) of this section may not contain any information that identifies the subject of the test.    (e)    An institution may not use a semen, blood, or tissue specimen from a donor with a positive HIV antibody test result obtained under the provisions of this section.
MD. Health - General Code Ann. §  18-335 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part VI - Acquired Immune Deficiency Syndrome (Aids)|Section 18-335 - Sale of Condoms by Vending Machines or Other Devices

    To properly ensure the quality and effectiveness of condoms sold by means of a vending machine or other automatic devices, the Secretary shall adopt regulations:         (1)    To protect the health, welfare, and safety of the public; and        (2)    To provide for the enforcement of this section.
MD. Health - General Code Ann. §  18-337 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part VI - Acquired Immune Deficiency Syndrome (Aids)|Section 18-337 - Positive Test Results

    (a)    In this section, “health care provider” means a physician, a physician’s designee, or a designee of a health care facility licensed or otherwise authorized to provide health care services.    (b)    If an individual informed of the individual’s HIV positive status under § 18-336 of this subtitle refuses to notify the individual’s sexual and needle-sharing partners, the individual’s physician may inform the local health officer and/or the individual’s sexual and needle-sharing partners of:        (1)    The individual’s identity; and        (2)    The circumstances giving rise to the notification.    (c)    When the local health officer is notified, the health officer shall enforce the provisions of §§ 18-208 through 18-213.1 of this title:        (1)    Within a reasonable time; and        (2)    To the extent feasible.    (d)    Each local health officer shall refer the infected individual and any known sexual or needle-sharing partners of the individual to appropriate services for the care, support, and treatment for HIV infected individuals.    (e)    A physician acting in good faith to provide notification in accordance with this section may not be held liable in any cause of action related to a breach of patient confidentiality.    (f)    A physician acting in good faith may not be held liable in any cause of action for choosing not to disclose information related to a positive test result for the presence of human immunodeficiency virus to an individual’s sexual and needle-sharing partners.    (g)    A hospital or any other health care provider acting in good faith pursuant to a physician’s order to perform or interpret a test for the presence of HIV may not be held liable in any cause of action related to:        (1)    A breach of patient confidentiality; or        (2)    A physician’s decision to disclose or not to disclose information related to a positive test result to a local health officer and/or an individual’s sexual and needle-sharing partners.
MD. Health - General Code Ann. §  18-338.2 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 3 - Specific Diseases|Part VI - Acquired Immune Deficiency Syndrome (Aids)|Section 18-338.2 - Pregnant Women

    (a)    (1)    In this section the following words have the meanings indicated.        (2)    “Health care facility” means a facility or office where health or medical care is provided to patients by a health care provider, including:            (i)    A hospital as defined in § 19–301 of this article;            (ii)    A facility operated by the Department or a health officer; and            (iii)    The office of a health care provider.        (3)    “Health care provider” means a physician, nurse, licensed direct–entry midwife, or designee of a health care facility.        (4)    “HIV” means the human immunodeficiency virus that causes acquired immune deficiency syndrome (AIDS).        (5)    “Prenatal care” means obstetric and gynecologic services performed as part of a prenatal care program, including:            (i)    Screening;            (ii)    Physical examination;            (iii)    Laboratory and diagnostic testing procedures and interpretation; and            (iv)    Counseling.    (b)    The Department, in consultation with stakeholders, shall adopt regulations establishing requirements for prenatal HIV testing.    (c)    (1)    A health care provider who provides prenatal medical care shallfollow the requirements for prenatal HIV testing that are adopted by the Department.        (2)    The Department shall provide the requirements established under subsection (b) of this section to:            (i)    Hospitals that offer obstetric services;            (ii)    The American College of Obstetricians and Gynecologists;            (iii)    The American College of Nurse Midwives; and            (iv)    The Association of Independent Midwives of Maryland.    (d)    (1)    Except as otherwise provided in paragraph (2) of this subsection, the record of an HIV test performed under this section is confidential and not discoverable or admissible in evidence in any criminal, civil, or administrative action.        (2)    Provided that the identity or any other information that could readily be associated with the identity of the pregnant woman is not disclosed, the results of an HIV test performed under this section may be introduced into evidence in any criminal, civil, or administrative action, including the adjudication of a workers’ compensation claim.    (e)    A health care provider may not be subject to disciplinary action by the professional licensing board that licenses the health care provider for following the requirements for prenatal HIV testing established by the Department.
MD. Health - General Code Ann. §  19-101 (2021)
2021 Maryland Statutes|Health - General|Title 19 - Health Care Facilities|Subtitle 1 - Health Care Planning and Systems Regulation|Part I - Maryland Health Care Commission|Section 19-101 - "Commission" Defined

    In this subtitle, “Commission” means the Maryland Health Care Commission.
MD. Health - General Code Ann. §  19-102 (2021)
2021 Maryland Statutes|Health - General|Title 19 - Health Care Facilities|Subtitle 1 - Health Care Planning and Systems Regulation|Part I - Maryland Health Care Commission|Section 19-102 - In General

    (a)    The General Assembly finds that the health care regulatory system in this State is a highly complex structure that needs to be constantly reevaluated and modified in order to better reflect and be more responsive to the ever changing health care environment and the needs of the citizens of this State.    (b)    The purpose of this subtitle is to establish a streamlined health care regulatory system in this State in a manner such that a single State health policy can be better articulated, coordinated, and implemented in order to better serve the citizens of this State.